InsidersTradesSigma
Track the OncoZenge AB share price and the full directors' dealings record of the company, a listed issuer based in Finland. Shares are listed on the FI market, under the oversight of FIN-FSA. Operating in the Health Care sector, OncoZenge AB has logged 4 reports. Market capitalisation: €116.6m. The latest transaction was reported on 28 November 2025 (Purchase). Among the most active insiders: Stian Kildal. The full history is free.
4
Insider Decl.
n/a
Thresholds
€76,548
4 ops.
Buy Volume
n/a
n/a
Sell Volume
47Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 28 November 2025
Declarations4 total
74,999 shares@ €0.48210.039% mcap76.8% of flowAktieISIN SE0015504097FI:A003U252-1
25,000 shares@ €0.57330.015% mcap100.0% of flowAktieISIN SE0015504097FI:A003S148-1
20,000 shares@ €0.54740.012% mcap23.2% of flowAktieISIN SE0015504097FI:A003N025-2
15,000 shares@ SEK 10.25100.0% of flowBTA (betald tecknad aktie)ISIN SE0015531231FI:A001R016-1
4 of 4 declarations
About OncoZenge AB
OncoZenge AB is a company focused on developing innovative cancer treatments. It is listed on the XSTO stock exchange.